-
Stanford University:
- Youn H. Kim, MD, Professor of Dermatology, Director of Stanford's Multidisciplinary Cutaneous Lymphoma Clinic/Program (MCLP)
- Project: Phase 2 study in Cutaneous T Cell Lymphoma: HemaMax in combination with Total Skin Electron Beam Therapy (TSEBT).
-
Duke University:
- Grace J. Kim, MD, PhD, Assistant Professor of Radiation Oncology
- Project: Triple Therapy in Resistant Melanoma and Non-small Cell Lung Cancer Patients: HemaMax, Opdivo or Keytruda (anti-PD-1) and Stereotactic Radiation.
-
Nantes University:
- Antoine Roquilly, MD, PhD, Anaesthesiology and Intensive Care Unit, Nantes University Hospital, France
- Project: International Study of HemaMax for the Treatment of Hospital Acquired Pneumonia.
